Singapore markets closed

Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
2.6800+0.0700 (+2.68%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
449,712
395,263
465,150
371,084
-1,077,699
-
Depreciation & amortisation
-
304,197
310,395
307,545
369,753
-
Change in working capital
-
34,174
-164,764
-807,015
-403,746
-
Inventory
-
-119,585
277,858
-166,457
124,643
-
Other working capital
411,170
863,136
532,448
-239,134
-846,365
-
Other non-cash items
-
63,818
67,522
72,800
34,342
-
Net cash provided by operating activities
-
949,671
622,093
-162,437
-728,154
-
Cash flows from investing activities
Investments in property, plant and equipment
-85,077
-86,535
-89,646
-76,696
-118,211
-
Purchases of investments
-2,998
-
-
-
-
-1,360,312
Sales/maturities of investments
-
589.4744
860.7134
848.8293
1,837
-
Other investing activities
-
-156,637
10,088
-10,000
21.7997
-
Net cash used for investing activities
-207,043
-206,644
72,336
91,615
-101,166
-
Net change in cash
501,231
891,893
872,789
319,538
231,222
-
Cash at beginning of period
2,295,470
2,064,246
1,191,457
871,919
640,698
-
Cash at end of period
2,796,018
2,956,139
2,064,246
1,191,457
871,919
-
Free cash flow
Operating cash flow
-
949,671
622,093
-162,437
-728,154
-
Capital expenditure
-85,077
-86,535
-89,646
-76,696
-118,211
-
Free cash flow
411,170
863,136
532,448
-239,134
-846,365
-